查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589642

大腸桿菌測試市場：通過測試、最終用戶 - 2025-2030 年全球預測

E. Coli Testing Market by Testing (Clinical, Environmental), End-User (Bottled Water Suppliers, Diagnostic Laboratories, Government Agencies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年大腸桿菌檢測市值為9.9617億美元，預計到2024年將達到10.9686億美元，複合年成長率為10.20%，預計到2030年將達到19.6626億美元。

E. 大腸桿菌檢測的範圍和定義包括旨在檢測大腸桿菌存在的診斷程序，並用於改善各領域的公共衛生和安全，包括食品和水安全、醫療診斷和藥物。為了滿足監管機構和消費者對嚴格安全通訊協定的要求，對大腸桿菌檢測的需求至關重要，因為大腸桿菌可能導致嚴重疾病和集體爆發。大腸桿菌測試在各種最終用途領域都有治療應用，包括需要快速診斷的醫療保健、需要嚴格測試標準以防止污染的食品行業，以及定期監測對公共很重要的水處理設施。的應用領域。

主要市場統計
基準年[2023] 9.9617億美元
預計年份 [2024] 1,096,860,000 美元
預測年份 [2030] 1,966.26 百萬美元
複合年成長率（%） 10.20%

市場成長主要受到人們對食品源性疾病和水源性疾病認知的提高、嚴格的政府法規、檢測方法的技術進步以及對預防性醫療保健的日益重視的影響。最新的潛在機會在於開發快速、經濟高效且靈敏的檢測套組，以及人工智慧和實驗室晶片技術的整合以提高準確性和效率。他們還應重點將測試解決方案擴展到低收入地區，以解決具有巨大成長潛力的未滿足需求。然而，先進檢測技術高成本、新興國家基礎設施缺乏以及監管障礙等限制因素為市場拓展帶來了挑戰。

創新和研究的最佳領域包括開發提供即時結果、縮短治療時間並改善管理結果的就地檢驗設備。此外，生物資訊學和次世代定序研究可以幫助我們更準確地檢測和分類大腸桿菌。市場競爭激烈，特點是持續的技術創新和策略合併，重點是加強產品系列。因此，投資研究合作以及與學術和醫療機構合作的公司可能會在這個不斷發展的環境中擁有競爭優勢。

市場動態：快速發展的大腸桿菌測試市場的關鍵市場洞察

大腸桿菌檢測市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 腹瀉病例數增加
    • 食品回收數量增加
    • 大量食用簡便食品
  • 市場限制因素
    • 大腸桿菌檢測缺乏標準化
  • 市場機會
    • 食品安全測量創新技術介紹
    • 持續開發 PCR 技術以改善病原體檢測
  • 市場挑戰
    • 測試食品和水的高成本

波特的五力：駕馭大腸桿菌測試市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解大腸桿菌檢測市場的外部影響

外部宏觀環境因素在塑造大腸桿菌檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 E. 了解大腸桿菌檢測市場的競爭狀況

對大腸桿菌測試市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 E. 大腸桿菌測試市場供應商績效評估

FPNV定位矩陣是評估大腸桿菌測試市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 E. 繪製大腸桿菌檢測市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對大腸桿菌檢測市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腹瀉發生率增加
      • 食品回收數量增加
      • 大量食用即食食品
    • 抑制因素
      • 大腸桿菌檢測缺乏標準化
    • 機會
      • 食品安全測量創新技術介紹
      • 持續開發 PCR 技術以改善病原體檢測
    • 任務
      • 食品和水測試成本高昂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 大腸桿菌測試市場

  • 臨床
    • 酵素免疫分析法
    • 聚合酵素鏈鎖反應
  • 環境
    • 酵素基材法
    • 薄膜過濾
    • 多管發酵

第 7 章 大腸桿菌測試市場：依最終使用者分類

  • 瓶裝水供應商
  • 診斷實驗室
  • 政府機構
  • 生活用水和飲用水供應商
  • 醫院
  • 污水處理機構

第8章 美洲大腸桿菌檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區大腸桿菌檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲大腸桿菌檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioSpace, Inc.
  • BIOTOXICITY
  • Caisson Labs Inc.
  • Corning Incorporated
  • Cygnus Technologies by Maravai LifeSciences
  • Enzo Life Sciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Intertek Group PLC
  • Lonza Group Ltd.
  • Merck & Co., Inc
  • Merck KGaA
  • SGS SA
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4348D129FACF

The E. Coli Testing Market was valued at USD 996.17 million in 2023, expected to reach USD 1,096.86 million in 2024, and is projected to grow at a CAGR of 10.20%, to USD 1,966.26 million by 2030.

The scope and definition of E. Coli testing encompass diagnostic procedures aimed at detecting the presence of Escherichia coli bacteria, crucial for ensuring public health and safety across various sectors, including food and water safety, medical diagnostics, and pharmaceuticals. The necessity of E. Coli testing is paramount due to the bacterium's potential to cause severe illness and outbreaks, driving regulatory and consumer demand for rigorous safety protocols. Applications of E. Coli testing cover diverse end-use sectors such as healthcare settings where rapid diagnostics are essential, the food industry which demands stringent testing standards to prevent contamination, and water treatment facilities where regular monitoring is critical to public safety.

KEY MARKET STATISTICS
Base Year [2023] USD 996.17 million
Estimated Year [2024] USD 1,096.86 million
Forecast Year [2030] USD 1,966.26 million
CAGR (%) 10.20%

Market growth is primarily influenced by increasing awareness of food and waterborne diseases, stringent government regulations, technological advancements in testing methods, and a growing emphasis on preventive healthcare. The latest potential opportunities lie in the development of rapid, cost-effective, and highly sensitive testing kits, as well as the integration of artificial intelligence and lab-on-a-chip technologies to enhance accuracy and efficiency. Efforts should also be directed towards expanding testing solutions to lower-income regions, addressing an unmet need with significant growth potential. However, limitations such as high costs of advanced testing technologies, lack of infrastructure in developing regions, and regulatory hurdles can pose challenges to market expansion.

The best areas for innovation and research include the development of point-of-care testing devices that allow for real-time results, thereby reducing time-to-treatment and improving management outcomes. Also, exploring bioinformatics and next-generation sequencing can foster even more accurate detection and classification of E. Coli strains. The market nature is competitive, characterized by ongoing technological innovation and strategic mergers, focusing on enhancement of product portfolios. Thus, businesses investing in robust research and collaborations with academic and healthcare institutions are likely to gain a competitive edge in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving E. Coli Testing Market

The E. Coli Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of diarrhea
    • Rise in numbers of food recalls
    • Significant consumption of convenience foods
  • Market Restraints
    • Lack of standardizations in E.coli testing
  • Market Opportunities
    • Introduction of innovative technologies in food safety measurements
    • Ongoing developments of PCR technology for improved pathogen testing
  • Market Challenges
    • Associated high cost of testing food and water

Porter's Five Forces: A Strategic Tool for Navigating the E. Coli Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the E. Coli Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the E. Coli Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the E. Coli Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the E. Coli Testing Market

A detailed market share analysis in the E. Coli Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the E. Coli Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the E. Coli Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the E. Coli Testing Market

A strategic analysis of the E. Coli Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the E. Coli Testing Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioSpace, Inc., BIOTOXICITY, Caisson Labs Inc., Corning Incorporated, Cygnus Technologies by Maravai LifeSciences, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., Intertek Group PLC, Lonza Group Ltd., Merck & Co., Inc, Merck KGaA, SGS SA, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the E. Coli Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Testing, market is studied across Clinical and Environmental. The Clinical is further studied across Enzyme Immunoassays and Polymerase Chain Reaction. The Environmental is further studied across Enzyme Substrate Methods, Membrane Filtration, and Multiple Tube Fermentation.
  • Based on End-User, market is studied across Bottled Water Suppliers, Diagnostic Laboratories, Government Agencies, Home & Drinking Water Suppliers, Hospitals, and Waste Water Treatment Agencies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of diarrhea
      • 5.1.1.2. Rise in numbers of food recalls
      • 5.1.1.3. Significant consumption of convenience foods
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standardizations in E.coli testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of innovative technologies in food safety measurements
      • 5.1.3.2. Ongoing developments of PCR technology for improved pathogen testing
    • 5.1.4. Challenges
      • 5.1.4.1. Associated high cost of testing food and water
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. E. Coli Testing Market, by Testing

  • 6.1. Introduction
  • 6.2. Clinical
    • 6.2.1. Enzyme Immunoassays
    • 6.2.2. Polymerase Chain Reaction
  • 6.3. Environmental
    • 6.3.1. Enzyme Substrate Methods
    • 6.3.2. Membrane Filtration
    • 6.3.3. Multiple Tube Fermentation

7. E. Coli Testing Market, by End-User

  • 7.1. Introduction
  • 7.2. Bottled Water Suppliers
  • 7.3. Diagnostic Laboratories
  • 7.4. Government Agencies
  • 7.5. Home & Drinking Water Suppliers
  • 7.6. Hospitals
  • 7.7. Waste Water Treatment Agencies

8. Americas E. Coli Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific E. Coli Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa E. Coli Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. Bio-Rad Laboratories, Inc.
  • 3. BioSpace, Inc.
  • 4. BIOTOXICITY
  • 5. Caisson Labs Inc.
  • 6. Corning Incorporated
  • 7. Cygnus Technologies by Maravai LifeSciences
  • 8. Enzo Life Sciences, Inc.
  • 9. F. Hoffmann-La Roche Ltd.
  • 10. Intertek Group PLC
  • 11. Lonza Group Ltd.
  • 12. Merck & Co., Inc
  • 13. Merck KGaA
  • 14. SGS SA
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. E. COLI TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. E. COLI TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL E. COLI TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. E. COLI TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL E. COLI TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. E. COLI TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME SUBSTRATE METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL E. COLI TESTING MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL E. COLI TESTING MARKET SIZE, BY MULTIPLE TUBE FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL E. COLI TESTING MARKET SIZE, BY BOTTLED WATER SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL E. COLI TESTING MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL E. COLI TESTING MARKET SIZE, BY HOME & DRINKING WATER SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTE WATER TREATMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2023